We conducted Kaplan–Meier survival analysis for each gene and found that AQP9, KIAA1429, and HAMP had a significant impact not only on the overall survival of ccRCC patients, but also on progression-free survival. This evidence concerns the gene AQP9 and nonpapillary renal cell carcinoma.